JPL Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$941 Buy
+78
New +$975 ﹤0.01% 1160

Other funds holding NTLA

JPL Wealth Management's NTLA Position: Q3 2026 in Review

JPL Wealth Management opened a new position in Intellia Therapeutics (NTLA) in Q3 2026: 78 shares worth $941. The stake represents ﹤0.01% of the portfolio and ranks #1160 among its holdings.

312 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • JPL Wealth Management held 78 shares of Intellia Therapeutics worth $941 as of Q3 2026.
  • Intellia Therapeutics was a new JPL Wealth Management position in Q3 2026.
  • Intellia Therapeutics made up ﹤0.01% of JPL Wealth Management's portfolio in Q3 2026, its #1160 holding.
  • 312 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.